PKI Beta Polyclonal Antibody

PKIB (protein kinase (cAMP-dependent, catalytic) inhibitor beta) encodes a member of the cAMP-dependent protein kinase inhibitor family. The encoded protein may play a role in the protein kinase A (PKA) pathway by interacting with the catalytic subunit of PKA, and overexpression of PKIB may play a role in prostate cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for PKIB.

The PKC Delta Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of protein kinase C delta (PKC Delta) in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity towards PKC Delta.

With its exceptional specificity, this polyclonal antibody enables accurate identification and quantification of PKC Delta in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other PKC isoforms, ensuring precise and reliable results.

The PKC Delta Polyclonal Antibody is manufactured under stringent quality control measures, guaranteeing batch-to-batch consistency and reproducibility. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and complex antibody preparation procedures.

This antibody demonstrates excellent performance in both research and clinical settings, making it an indispensable tool for scientists and clinicians studying PKC Delta's role in various cellular processes and diseases. Its robustness and versatility make it suitable for use in diverse experimental models and sample types.

Choose the PKC Delta Polyclonal Antibody for its exceptional specificity, reliability, and ease of use, and unlock new insights into the intricate mechanisms involving PKC Delta.